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  Thirty fernale patients with acute simp｝e cystitis were treated with oral cefradine at a daily dose
of 750 mg or 1，000 mg for 3， 4 or 5 days， and the therapeutic results were evaluated by the criteria
proposed by the UTI Committee， Japan．
1） The overall clinical efficacies of treatment were excellent in 26 （86．7G／．）， moderate in 3 （10．00／．）
 and poor in only one． Overall effectiveness rate was 96．70／．．
2） As to drug－related side effects， stornach ache and eruption were observed in two patients．
  The results indicated that cefradine is very effective and safe drug for acute simple cystitis．
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Table 2． Overall clinical eMcacy of cefradine （CED） in acute simple cystitis 250 rng x 3－4／day， 3－5days treatment




























Eliminated26 1「 27    （90●0％ ）
BacteriuriaDecreased
iRe laced）
1 1  （3．3％）
Unchanged・ 1 1 2  （6．7％）
Efficacy o亭  ． ．        pa■n on ur＝Lnat■on
29      （96・7％ ．） 0  （0 ％） 1．@ （ 3．3％）
Efficacy on Pyu「ia28      （93．3 ％ ） 0  （0 ％） 2  （6．7％）
Case  Tota1
@  30
Excellent 26        （  86。7 ％ ）
Moderate 3      （ 10。0％ ）
Overall effectiveness rate
@   29／30          （  96．7 ％ ）







Table 3． Bacteriological response to cefradine （CED） in acute simple cystitis





























Tota1 30 27 （ 90 ％） 3
                    sc Persisted ： regardless of bacterial count
Table 4． Relation between MIC and bacteriological response in cefradine （CED） treatment
Isolates MIC （ iu g／ml ） 工noculum siseio6cens／mi Notdone Total






















































































































































































































































Deteriorated （ Relation to the drug ）
Defini亡e Probable P。ssible Subt・ta1Probablynot













































































      症状により適宜増減。．










   包装20m15管・30管s sm15管・50管，2 ml 10eV・100管
       ※使用上の注意は，製品の添付文書をご参照下さい。
   ●内服療法‘二は2曜盟督1回7；錠二号
                      包装 1000錠，5000錠
財難ミノファーゲン製薬本舗（〒160）東京都新宿区新宿3－1－12
